Your browser doesn't support javascript.
loading
Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients.
Sasaki, Takeshi; Franco, Omar E; Ohishi, Kohshi; Filipovich, Yana; Ishii, Kenichiro; Crawford, Susan E; Takahashi, Naoto; Katayama, Naoyuki; Sugimura, Yoshiki; Hayward, Simon W.
Affiliation
  • Sasaki T; Department of Surgery, NorthShore University HealthSystem, Affiliate of University of Chicago Pritzker School of Medicine, Evanston, Illinois.
  • Franco OE; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
  • Ohishi K; Department of Surgery, NorthShore University HealthSystem, Affiliate of University of Chicago Pritzker School of Medicine, Evanston, Illinois.
  • Filipovich Y; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
  • Ishii K; Department of Transfusion Medicine and Cell Therapy, Mie University Hospital, Tsu, Mie, Japan.
  • Crawford SE; Department of Surgery, NorthShore University HealthSystem, Affiliate of University of Chicago Pritzker School of Medicine, Evanston, Illinois.
  • Takahashi N; Department of Oncologic Pathology, Mie University, Graduate School of Medicine, Tsu, Mie, Japan.
  • Katayama N; Department of Surgery, NorthShore University HealthSystem, Affiliate of University of Chicago Pritzker School of Medicine, Evanston, Illinois.
  • Sugimura Y; Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Akita, Japan.
  • Hayward SW; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Prostate ; 79(3): 259-264, 2019 02.
Article in En | MEDLINE | ID: mdl-30370673
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Pyrimidines / Kallikreins / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Prostate-Specific Antigen / Protein Kinase Inhibitors / Imatinib Mesylate Limits: Aged / Humans / Male Language: En Journal: Prostate Year: 2019 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Pyrimidines / Kallikreins / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Prostate-Specific Antigen / Protein Kinase Inhibitors / Imatinib Mesylate Limits: Aged / Humans / Male Language: En Journal: Prostate Year: 2019 Type: Article